From Protocol to Successful Fundraising: How Biotechs Build Investor-Ready Clinical Study Budgets

Fundraising in biotech has changed.

It’s no longer enough to have strong science.

Investors now expect credible clinical plans, realistic budgets, and a clear execution strategy.

This session brings together real-world insights on how biotech teams can move from high-level assumptions to defensible, investor-ready clinical plans.

Why Many Biotech Fundraising Efforts Fall Short

Most challenges don’t come from the science.

They come from gaps in planning:

• timelines that don’t reflect execution reality
• budgets built on incomplete assumptions
• limited visibility into vendor costs and drivers
• disconnect between clinical, finance, and outsourcing

These gaps are quickly identified during investor discussions.

What Investors Actually Look For

Today’s investors are asking:

• How realistic are your timelines?
• How robust are your cost assumptions?
• How well do you understand execution complexity?

In short: Can this plan actually be delivered?

Where Clinical Plans Break Down

The biggest risks appear between: protocol design, budgeting, and execution.

Typical breakdowns include:

• underestimating global trial complexity
• misaligned assumptions across teams
• lack of structured RFP and vendor evaluation
• limited benchmarking of cost drivers

The result: delays, budget increases, and reduced confidence.

Outsourcing: Necessary — but Increasing Complexity

Outsourcing is not a shortcut.

It introduces:

• more vendors
• more dependencies
• more interfaces

Without structure:

• less visibility
• less control
• more risk

What Changes the Outcome

Biotech teams that succeed in fundraising:

• build budgets based on realistic scenarios
• understand key cost drivers and assumptions
• align clinical, financial, and outsourcing perspectives
• bring structure into RFP and vendor evaluation

They move from estimates to defensible plans.

Key Takeaways

• fundraising success depends on operational credibility
• clinical planning must reflect execution reality
• outsourcing strategy impacts budgets and timelines
• structured data and benchmarking improve confidence

👉 Watch the Webinar Recording

Apply This to Your Programs

If you are preparing for fundraising or planning your next study:

👉 Request a Demo to explore how to bring more structure and confidence into your clinical planning.